793 Multicenter phase II study of gemcitabine-oxaliplatin (GEMOX) chemotherapy in untreated locally advanced or metastatic non-small cell lung cancer (NSCLC) patients

F.Cappuzzo; S.Novello; F.De Marinis; M.Maur; G.Scagliotti; S.Salvagni; E.Crucitta; S.Bartolini; A.Maestri; L.Crino

首页> 外文期刊>European Journal of Cancer Supplements >793 Multicenter phase II study of gemcitabine-oxaliplatin (GEMOX) chemotherapy in untreated locally advanced or metastatic non-small cell lung cancer (NSCLC) patients

【24h】

793 Multicenter phase II study of gemcitabine-oxaliplatin (GEMOX) chemotherapy in untreated locally advanced or metastatic non-small cell lung cancer (NSCLC) patients

机译：793吉西他滨-奥沙利铂（GEMOX）化疗在未经治疗的局部晚期或转移性非小细胞肺癌（NSCLC）患者中的多中心II期研究

获取原文

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《European Journal of Cancer Supplements》 |2003年第5期|共1页
作者
F.Cappuzzo; S.Novello; F.De Marinis; M.Maur; G.Scagliotti; S.Salvagni; E.Crucitta; S.Bartolini; A.Maestri; L.Crino;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. 793 Multicenter phase II study of gemcitabine-oxaliplatin (GEMOX) chemotherapy in untreated locally advanced or metastatic non-small cell lung cancer (NSCLC) patients [J] . F.Cappuzzo, S.Novello, F.De Marinis, European Journal of Cancer Supplements . 2003,第5期

机译：793吉西他滨-奥沙利铂（GEMOX）化疗在未经治疗的局部晚期或转移性非小细胞肺癌（NSCLC）患者中的多中心II期研究
2. Gemcitabine plus oxaliplatin combination (GEMOX regimen) in pretreated patients with advanced non-small cell lung cancer (NSCLC): a multicenter phase II study. [J] . Kakolyris S, Ziras N, Vamvakas L, Lung cancer: Journal of the International Association for the Study of Lung Cancer . 2006,第3期

机译：吉西他滨联合奥沙利铂联合治疗（GEMOX方案）在患有晚期非小细胞肺癌（NSCLC）的患者中进行的一项多中心II期研究。
3. A multicenter, randomized, phase III study of docetaxel plus best supportive care versus best supportive care in chemotherapy-naive patients with metastatic or non-resectable localized non-small cell lung cancer (NSCLC). [J] . Roszkowski K, Pluzanska A, Krzakowski M, Lung cancer: Journal of the International Association for the Study of Lung Cancer . 2000,第3期

机译：多西紫杉醇联合最佳支持治疗与最佳支持治疗的多中心，随机，III期研究，针对未接受化疗的转移性或不可切除的局部非小细胞肺癌（NSCLC）患者。
4. The clinical efficacy of transfusion of cytokine-induced killer cells combined with chemotherapy and XiaoJi decoction in patients with stage IIIB/IV non-small cell lung cancer [C] . Liuning Li, Jiaying Liu, Xiaoshu Chai, IEEE International Conference on Bioinformatics and Biomedicine . 2014

机译：细胞因子诱导的杀伤细胞输注结合化学疗法和消积汤治疗IIIB / IV期非小细胞肺癌的临床疗效
5. Assessing the effectiveness of palliative chemotherapy for non-small cell lung cancer: A phase IV study of patients treated at Ontario's cancer centres [D] . Harrison, Lyndsay Dawn. 2012

机译：评估姑息化疗对非小细胞肺癌的有效性：在安大略省癌症中心接受治疗的患者的IV期研究
6. GEMSTONE-301: a phase III clinical trial of CS1001 as consolidation therapy in patients with locally advanced/unresectable (stage III) non-small cell lung cancer (NSCLC) who did not have disease progression after prior concurrent/sequential chemoradiotherapy [O] . Qing Zhou, Ming Chen, Gang Wu, 2020

机译：Gemstone-301：CS1001的III期临床试验作为局部晚期/不可切除（第III阶段）非小细胞肺癌（NSCLC）在先前同时/顺序化学疗法后没有疾病进展的患者的固结治疗
7. PRS-03: Phase III study of pemetrexed plus cisplatin versus gemcitabine plus cisplatin in chemonaive patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) [O] . Scagliotti Giorgio, Purvish Parikh, von Pawel Joachim, 2007

机译：PRS-03：培美曲塞加顺铂与吉西他滨加顺铂在局部晚期或转移性非小细胞肺癌（NSCLC）化疗阳性患者中的III期研究

793 Multicenter phase II study of gemcitabine-oxaliplatin (GEMOX) chemotherapy in untreated locally advanced or metastatic non-small cell lung cancer (NSCLC) patients

著录项

相似文献

相关主题

期刊订阅